DOI: https://doi.org/10.24959/cphj.18.1472

Renal effects of the sulfur-containing aminoacid derivatives (ademetionine, taurin and glutathion) in conditionally healthy animals

V. M. Drachuk, I. I. Zamorskii, T. S. Shchudrova, O. M. Goroshko

Abstract


Derivatives of sulfur-containing aminoacids (ademetionin, taurine and glutathione) selected for the experimental studies are used in various fields of practical medicine due to their multifaceted pleiotropic effects. The study of their renal effects in the conditions of the physiological norm makes it possible to expand and supplement their pharmacological characteristics, and forms the basis for further study of the nephroprotective potential in renal pathology.

Aim. To study the effect of sulfur-containing amino acid derivatives (ademetionine, taurine andglutathione) on the morphofunctional state of the rat kidneys in the daily administration for 7 days.

Materials and methods. The experiments were performed on mature non-linear white rats weighing 130-180 g. Animals were divided into 4 groups (n = 7): group I – intact control, group II – animals which were given ademetionine (“Geptral”, “Abbott SpA”, Italy) in the dose of 20 mg/kg, group III – animals received taurine (“Sigma-Aldrich”, USA) in the dose of 100 mg/kg, group IV – animals received glutathione (“TAD 600”, “Biomedica Foscama”, Italy) in the dose of 30 mg/kg. All drugs were injected intramuscularly for 7 days.

Results. The study of the renal effects of the sulfur-containing amino acid derivatives (SAD) under research in the daily administration for 7 days to conditionally healthy animals showed that these drugs had a weak diuretic effect, which was probably due to a decreased tubular reabsorption of water without significant changes in the glomerular filtration rate. Besides, the use of ademetionine resulted in a slight reduction of azotemia. There was not any significant change in the acid regulatory kidney function under the effect of SAD. Administration of ademetionine, taurine and glutathione resulted in a significant decrease in proteinuria, which was probably caused by the effect on the processes of protein reabsorption. The effect on the ion regulatory kidney function upon the course of SAD administration was characterized by an increase in urinary sodium excretion against the background of decreased relative sodium reabsorption, which was accompanied by intensification of distal transport of sodium ions due to the activation of the tubular-tubular balance. The morphological examination did not reveal any histopathological changes in the renal tissue, confirming the absence of nephrotoxicity of the SAD studied.

Conclusions. According to the data obtained the 7-day administration of ademetionine, taurine and glutathione to conditionally healthy animals moderately affects the processes of glomerular filtration and tubular transport in nephrons, which results in a slight increase in diuresis along with preservation of the renal mechanisms of autoregulation and the absence of histopathological changes in the kidneys.


Keywords


renal effects; ademetionine; taurine; glutathione

Full Text:

PDF

References


Semidotckaia, Zh. D., Cherniakova, I. A., Pionova, E. N., Trifonova, N. S. (2017). East European Journal of Internal and Family Medicine, 1, 10–16.

Dennis, J. M., Witting, P. K. (2017). Protective Role for Antioxidants in Acute Kidney Disease. Nutrients, 9(7), 718. https://doi.org/10.3390/nu9070718

Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016). Oxidant Mechanisms in Renal Injury and Disease. Antioxidants & Redox Signaling, 25(3), 119–146. https://doi.org/10.1089/ars.2016.6665

Yurev, K. L. (2012). Ukrainskyi medychnyi chasopys, 1 (87), 10–16.

Zviahyntseva, T. D., Chernobai, A. Y., Hlushchenko, S. V. (2014). Ukrainskyi medychnyi chasopys, 3 (101), 56–59.

Anstee, Q. M., & Day, C. P. (2012). S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility. Journal of Hepatology, 57(5), 1097–1109. https://doi.org/10.1016/j.jhep.2012.04.041

Geptral instrukciya, zastosuvannya preparatu. (n.d.). Available at: http://mozdocs.kiev.ua/likivi ew.php?id=31805

Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., … Domenicotti, C. (2013). Role of Glutathione in Cancer Progression and Chemoresistance. Oxidative Medicine and Cellular Longevity, 2013, 1–10. https://doi.org/10.1155/2013/972913

Saliga, N. O. (2013). Ukraïns’kij bìofarmacevtičnij žurnal, 85 (4), 40–47.

Forman, H. J., Zhang, H., & Rinna, A. (2009). Glutathione: Overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine, 30(1-2), 1–12. https://doi.org/10.1016/j.mam.2008.08.006

Lushchak, V. I. (2012). Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions. Journal of Amino Acids, 2012, 1–26. https://doi.org/10.1155/2012/736837

Hepaval. (n.d.). Available at: https://compendium.com.ua/info/220085/gepaval/

Ostapiv, R. D., Kystsiv, O. S., Manko, V. V. (2015). Visnyk Lvivskoho universytetu seriia Biolohiia, 69, 247–255.

Lambert, I. H., Kristensen, D. M., Holm, J. B., & Mortensen, O. H. (2014). Physiological role of taurine - from organism to organelle. Acta Physiologica, 213(1), 191–212. https://doi.org/10.1111/apha.12365

Yan-Jun, Xu., Amarjit, S. A., Paramjit, S. T., Naranjan, S. D. (2008). The potential health benefits of taurine in cardiovascular disease. Exp Clin Cardiol, 13(2), 57–65.

Kumari, N., Prentice, H., & Wu, J.-Y. (2013). Taurine and Its Neuroprotective Role. Taurine 8, 19–27. https://doi.org/10.1007/978-1-4614-6130-2_2

Shimada, K., Jong, C. J., Takahashi, K., & Schaffer, S. W. (2015). Role of ROS Production and Turnover in the Antioxidant Activity of Taurine. Advances in Experimental Medicine and Biology, 803, 581–596. https://doi.org/10.1007/978-3-319-15126-7_47

Taufon, instruktsiia, zastosuvannia preparatu. (n.d.). Available at: http://mozdocs.kiev.ua/likiview.php?id=31670

Council Directive 2010/63/EU of 22 September 2010 on the protection of animals used for scientific purposes. (2010). Official Journal of the European Communities, 276, 33–79.

Kamyshnikov, V. S. (2009). Spravochnik po kliniko-biokhimicheskim issledovaniiam i laboratornoi diagnostike, (3-edition). Moscow: «MEDpressinform», 896.


GOST Style Citations


1. Острое повреждение почек: современний взгляд на проблему / Ж. Д. Семидоцкая, И. А. Чернякова, Е. Н. Пионова, Н. С. Трифонова // Східноєвропейський журнал внутрішньої та сімейної медицини. – 2017. – Т. 1. – С. 10–16.

2. Dennis J. M. Protective Role for Antioxidants in Acute Kidney Disease / J. M. Dennis, P. K. Witting // Nutrients. – 2017. – № 9 (7). – P. 718. https://doi.org/10.3390/nu9070718

3. Ratliff, B. B. Oxidant mechanisms in renal injury and disease / B. B. Ratliff, W. Abdulmahdi, R. Pawar, M. S. Wolin // Antioxid. Redox Signal. – 2016. – № 25. – P. 119–146. https://doi.org/10.1089/ars.2016.6665

4. Юрьев, К. Л. Гептрал (адеметионин) – гепатопротектор и антидепресант / К. Л. Юрьев // Укр. мед. часопис. – 2012. – № 1 (87). – С. 10–16.

5. Звягинцева, Т. Д. Роль адеметионина в развитии и прогрессировании хронических заболеваний печени / Т. Д. Звягинцева, А. И. Чернобай, С. В. Глущенко // Укр. мед. часопис. – 2014. – № 3 (101). – С. 56–59.

6. Anstee, Q. M. S-adenosylmethionine (SAMe) therapy in liver disease: are view of current eviden ceand clinical utility // Q. M. Anstee, C. P. Day / J. Hepatol. – 2012. – Vol. 57 (5). – P. 1097–1109. https://doi.org/10.1016/j.jhep.2012.04.041

7. Гептрал, інструкція, застосування препарату [Електронний ресурс]. Режим доступу: http://mozdocs.kiev.ua/likivi ew.php?id=31805.

8. Role of Glutathione in Cancer Progression and Chemoresistanc / N. Traverso, R. Ricciarelli, M. Nitti, [et al.] // Oxid Med Cell Longev. – 2013. – № 2013. – P. 1–10. https://doi.org/10.1155/2013/972913

9. Салига, Н. О. Активність глутатіонової системи антиоксидантного захисту в щурів за дії L-глутамінової кислоти / Н. О. Салига // Укр. біохім. Журн. – 2013. – №85 (4). – С. 40–47.

10. Forman, H. J. Glutathione: Overview of its protective roles, measurement, and biosynthesis / H. J. Forman, H. Zhang, A. Rinna // Mol Aspects Med. – 2009. – Vol. 30(1-2). – P.1–12. https://doi.org/10.1016/j.mam.2008.08.006

11. Lushchak, V. I. Glutathione Homeostasis and Functions: Potential Targets for Medical / V. I. Lushchak // Interventions Journal of Amino Acids. – 2012. – P. 26. https://doi.org/10.1155/2012/736837

12. Гепавал [Електронний ресурс] / Компендиум – Лекарственные препараты. – Режим доступу: https://compendium.com.ua/info/220085/gepaval/

13. Остапів, Р. Д. Вплив таурину на фізіологічні показники щурів / Р. Д. Остапів, О. С. Кисців, В. В. Манько // Вісник Львівського університету серія Біологія. – 2015. – №69. – С. 247–255.

14. Physiological role of taurine-from organism to organelle / I. H. Lambert, D. M. Kristensen, J. B. Holm, O. H. Mortensen // Acta Physiol. (Oxf). – 2015. – Vol. 213(1). – P.191–212. https://doi.org/10.1111/apha.12365

15. The potential health benefits of taurine in cardiovascular disease / Xu. Yan-Jun, S. A. Amarjit, S. T. Paramjit, S. D. Naranjan // Exp Clin Cardiol. – 2008. –№ 13(2). – P. 57–65.

16. Kumari, N. Taurine and its neuroprotective role / N. Kumari, H. Prentice, J. Y. Wu // Adv Exp Med Biol. – 2013. – Vol. 775. – P. 19–27. https://doi.org/10.1007/978-1-4614-6130-2_2

17. Role of ROS production and turnover in the antioxidant activity of taurine / K. Shimada, C. J. Jong, K. Takahashi, S. W. Schaffer // Adv. Exp. Med. Biol. – 2015. – Vol. 803. – P. 581–596. https://doi.org/10.1007/978-3-319-15126-7_47

18. Тауфон, інструкція, застосування препарату [Електронний ресурс]. Режим доступу: http://mozdocs.kiev.ua/likiview.php?id=31670

19. Council Directive 2010/63/EU of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Communities. – 2010. – L. 276. – Р. 33 – 79.

20. Камышников, В. С. Справочник по клинико-биохимическим исследованиям и лабораторной диагностике, 3-е изд. / В. С. Камышников. – Москва: «МЕДпрессинформ», 2009. – 896 с.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Klìn. farm.

ISSN 2518-1572 (Online), ISSN 1562-725X (Print)